Loading viewer...
earnings
Format: PDF earnings
Teva Pharmaceutical Industries presents second quarter 2023 financial results and operational performance, covering generic pharmaceuticals, innovative medicines including AUSTEDO and COPAXONE, and biosimilar portfolio development. The presentation addresses competitive positioning, pipeline strategies, and risk factors affecting the company's outlook in a dynamic pharmaceutical market.
earnings
37 Pages
earnings
21 Pages
4iG
Pinnacle Financial Q2 2024 Investor Call July 17
earningsearnings
56 Pages
Pinnacle Financial International, Inc.
ANZ Group Holdings 2023 Full Year Results Presentation
earningsearnings
157 Pages
ANZ Group Holdings Limited